Short Interest in Raia Drogasil S.A. (OTCMKTS:RADLY) Increases By 2,061.7%

Raia Drogasil S.A. (OTCMKTS:RADLYGet Free Report) was the target of a significant growth in short interest during the month of May. As of May 29th, there was short interest totaling 10,333 shares, a growth of 2,061.7% from the May 14th total of 478 shares. Approximately 0.0% of the shares of the company are sold short. Based on an average daily volume of 67,516 shares, the short-interest ratio is currently 0.2 days.

Analyst Ratings Changes

Separately, Zacks Research raised Raia Drogasil to a “hold” rating in a research report on Thursday, April 9th. One research analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold”.

Get Our Latest Analysis on RADLY

Raia Drogasil Stock Down 2.6%

Shares of RADLY stock traded down $0.09 during trading hours on Tuesday, reaching $3.43. 7,083 shares of the company traded hands, compared to its average volume of 19,914. Raia Drogasil has a 12-month low of $2.21 and a 12-month high of $5.34. The firm has a 50-day moving average price of $4.24 and a 200 day moving average price of $4.49.

About Raia Drogasil

(Get Free Report)

Raia Drogasil SA is a leading Brazilian retail pharmacy operator, offering a comprehensive range of prescription and over-the-counter medications, health and wellness products, personal care and beauty items, as well as a selection of convenience goods. The company’s network of stores operates under the Raia and Drogasil banners, serving diverse consumer needs across major urban centers. Complementary services include in-store prescription dispensing, compounding pharmacies and health screening programs such as blood pressure and glucose monitoring.

The company was formed in 2011 through the merger of two established Brazilian pharmacy chains, Drogasil and Droga Raia, each with origins dating back several decades.

Further Reading

Receive News & Ratings for Raia Drogasil Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Raia Drogasil and related companies with MarketBeat.com's FREE daily email newsletter.